X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (179) 179
Publication (49) 49
Conference Proceeding (6) 6
Book / eBook (1) 1
Book Chapter (1) 1
Book Review (1) 1
Dissertation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (103) 103
male (78) 78
female (76) 76
rheumatology (75) 75
index medicus (73) 73
middle aged (62) 62
adult (54) 54
aged (52) 52
article (39) 39
vasculitis (36) 36
disease (28) 28
abridged index medicus (27) 27
aged, 80 and over (23) 23
adolescent (22) 22
cohort studies (20) 20
wegeners-granulomatosis (19) 19
giant cell arteritis (18) 18
treatment outcome (18) 18
polymyositis (17) 17
severity of illness index (17) 17
dermatomyositis (16) 16
immunosuppressive agents - therapeutic use (15) 15
rheumatoid-arthritis (14) 14
risk factors (14) 14
follow-up studies (13) 13
medicine, general & internal (13) 13
patients (13) 13
retrospective studies (13) 13
antineutrophil cytoplasmic antibodies (12) 12
biomarkers - blood (12) 12
case-control studies (12) 12
child (12) 12
idiopathic inflammatory myopathies (12) 12
polymyalgia-rheumatica (12) 12
prospective studies (12) 12
therapy (12) 12
young adult (12) 12
arteritis (11) 11
granulomatosis with polyangiitis - drug therapy (11) 11
pathogenesis (11) 11
remission induction (11) 11
classification (10) 10
diagnosis (10) 10
inflammation (10) 10
arthritis (9) 9
autoantibodies (9) 9
autoimmune diseases (9) 9
biopsy (9) 9
granulomatosis (9) 9
remission (9) 9
research (9) 9
united states (9) 9
association (8) 8
double-blind method (8) 8
expression (8) 8
follow-up (8) 8
giant-cell arteritis (8) 8
granulomatosis with polyangiitis (8) 8
juvenile dermatomyositis (8) 8
longitudinal studies (8) 8
methotrexate (8) 8
myositis (8) 8
recurrence (8) 8
rituximab (8) 8
sensitivity and specificity (8) 8
term-follow-up (8) 8
time factors (8) 8
wegener's granulomatosis (8) 8
anca-associated vasculitis (7) 7
biomarkers (7) 7
c-reactive protein (7) 7
clinical trials (7) 7
diagnosis, differential (7) 7
disease progression (7) 7
education, scientific disciplines (7) 7
epidemiology (7) 7
etanercept (7) 7
genetic predisposition to disease (7) 7
glucocorticoids - therapeutic use (7) 7
granulomatosis with polyangiitis - immunology (7) 7
incidence (7) 7
microscopic polyangiitis (7) 7
population (7) 7
prognosis (7) 7
randomized-trial (7) 7
systemic-lupus-erythematosus (7) 7
alleles (6) 6
anca (6) 6
animals (6) 6
care and treatment (6) 6
criteria (6) 6
cyclophosphamide (6) 6
drug therapy (6) 6
genetic aspects (6) 6
genome-wide association study (6) 6
giant cell arteritis - complications (6) 6
giant cell arteritis - drug therapy (6) 6
granulomatosis with polyangiitis - complications (6) 6
haplotypes (6) 6
klinikai orvostudományok (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1988, Volume 55, no. 6., 435-510.
Book
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 5, pp. 417 - 427
This study of ANCA-associated vasculitis compared a single course of rituximab with conventional immunosuppression with cyclophosphamide followed by... 
WEGENERS-GRANULOMATOSIS | MAINTENANCE | MEDICINE, GENERAL & INTERNAL | ANTIBODY-ASSOCIATED VASCULITIS | RENAL VASCULITIS | CYCLOPHOSPHAMIDE | RITUXIMAB | ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES | RANDOMIZED-TRIAL | SYSTEMIC VASCULITIDES | CELL-ACTIVATION | Recurrence | Azathioprine - therapeutic use | Glucocorticoids - therapeutic use | Double-Blind Method | Drug Administration Schedule | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Immunologic Factors - administration & dosage | Kaplan-Meier Estimate | B-Lymphocytes | Rituximab | Cyclophosphamide - adverse effects | Remission Induction | Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - drug therapy | Cyclophosphamide - therapeutic use | Immunosuppressive Agents - adverse effects | Immunologic Factors - adverse effects | Drug Therapy, Combination | Antibodies, Monoclonal, Murine-Derived - adverse effects | Azathioprine - adverse effects | Antibodies, Monoclonal, Murine-Derived - therapeutic use | Immunologic Factors - therapeutic use | Immunosuppression | Vasculitis | Drug therapy | Patient outcomes | Disease | Medical treatment | Hypersensitivity | Patients | Immunosuppressive agents | Cyclophosphamide | Infectious diseases | Lymphocytes B | Antineutrophil cytoplasmic antibodies | Remission | Azathioprine
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2010, Volume 363, Issue 3, pp. 221 - 232
Journal Article
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 12/2017, Volume 76, Issue 12, pp. 1955 - 1964
Journal Article
Arthritis & Rheumatology, ISSN 2326-5191, 04/2017, Volume 69, Issue 4, pp. 837 - 845
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2016, Volume 35, Issue 9, pp. 1140 - 1144
Journal Article
The American Journal of Human Genetics, ISSN 0002-9297, 08/2013, Volume 93, Issue 2, pp. 298 - 305
Journal Article